Silverarc Capital Management, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Silverarc Capital Management, LLC disclosed 73 US equity positions worth $690.7m in its Q3 2025 13F filing. The largest position was ABVX at 6.6% of the reported book, followed by RYTM and RNAGBP. Against the Q2 2025 filing, it opened 19 new positions, added to 21 and reduced 9 among the top 50 holdings.
What did Silverarc Capital Management, LLC own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ABVX ABIVAX SA | 6.6% | $45.8m | 539,704 | – | new | |
| 2 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 5.4% | $37.4m | 369,996 | -8% | reduced |
| 3 | RNAGBP AVIDITY BIOSCIENCES INC | 5.3% | $36.8m | 844,633 | 106% | added | |
| 4 | NUVALENT INC | 4.7% | $32.2m | 372,300 | 58% | added | |
| 5 | URGN UROGEN PHARMA LTD | Healthcare | 4.6% | $31.5m | 1,577,283 | -22% | reduced |
| 6 | AKERO THERAPEUTICS INC | 4.4% | $30.6m | 643,636 | -10% | reduced | |
| 7 | INSM INSMED INC | Healthcare | 4.3% | $29.8m | 206,648 | -17% | reduced |
| 8 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 3.8% | $26.6m | 674,966 | 605% | added |
| 9 | QURE UNIQURE NV | 3.8% | $26.6m | 455,000 | 125% | added | |
| 10 | CGON CG ONCOLOGY INC | Healthcare | 3.7% | $25.7m | 638,346 | 18% | added |
| 11 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 3.4% | $23.4m | 1,948,808 | 8% | added |
| 12 | CDTX CIDARA THERAPEUTICS INC | 3.1% | $21.2m | 220,902 | 113% | added | |
| 13 | GUTS FRACTYL HEALTH INC | 2.4% | $16.9m | 10,600,000 | 5132% | added | |
| 14 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.4% | $16.6m | 1,363,378 | -26% | reduced | |
| 15 | KOD KODIAK SCIENCES INC | Healthcare | 2.4% | $16.4m | 1,000,000 | 149% | added |
| 16 | GOSS GOSSAMER BIO INC | Healthcare | 1.8% | $12.6m | 4,779,082 | -7% | reduced |
| 17 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.7% | $11.7m | 815,075 | – | new |
| 18 | CYTK CYTOKINETICS INC | Healthcare | 1.7% | $11.6m | 211,000 | – | new |
| 19 | PCVX VAXCYTE INC | Healthcare | 1.6% | $11.3m | 314,339 | 9% | added |
| 20 | BIIB BIOGEN INC | Healthcare | 1.6% | $11.3m | 80,419 | – | new |
| 21 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.5% | $10.6m | 53,554 | -38% | reduced |
| 22 | CMPX COMPASS THERAPEUTICS INC | 1.4% | $9.9m | 2,833,988 | 127% | added | |
| 23 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 1.4% | $9.5m | 700,000 | – | new |
| 24 | VSTM VERASTEM INC | Healthcare | 1.3% | $9.2m | 1,042,757 | – | new |
| 25 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.3% | $9.2m | 720,922 | – | new |
| 26 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.3% | $9.1m | 933,541 | – | new |
| 27 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.3% | $9.0m | 348,922 | 76% | added |
| 28 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.3% | $8.7m | 233,920 | -31% | reduced |
| 29 | VCYT VERACYTE INC | Healthcare | 1.2% | $8.1m | 235,791 | -47% | reduced |
| 30 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.0% | $7.1m | 463,708 | 15% | added |
| 31 | RAPP RAPPORT THERAPEUTICS INC | 0.9% | $6.1m | 203,946 | – | new | |
| 32 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.8% | $5.6m | 259,509 | – | new |
| 33 | ALKS ALKERMES PLC | Healthcare | 0.8% | $5.4m | 180,513 | – | new |
| 34 | TRVI TREVI THERAPEUTICS INC | Healthcare | 0.8% | $5.4m | 588,789 | 9% | added |
| 35 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.8% | $5.3m | 457,414 | – | new | |
| 36 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.8% | $5.3m | 994,754 | 8% | added |
| 37 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.7% | $5.2m | 778,611 | – | new |
| 38 | GLUE MONTE ROSA THERAPEUTICS INC | 0.7% | $5.1m | 694,942 | – | new | |
| 39 | CGEN COMPUGEN LTD | Healthcare | 0.7% | $4.9m | 3,311,165 | 9% | added |
| 40 | PHVS PHARVARIS N V | 0.7% | $4.6m | 183,903 | – | new | |
| 41 | CELC CELCUITY INC | Healthcare | 0.6% | $4.4m | 88,686 | – | new |
| 42 | CERS CERUS CORP | Healthcare | 0.6% | $4.3m | 2,715,786 | 9% | added |
| 43 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.6% | $4.2m | 1,897,383 | – | new |
| 44 | TELA TELA BIO INC | 0.6% | $4.1m | 2,782,923 | 0% | held | |
| 45 | AARD AARDVARK THERAPEUTICS INC | 0.6% | $4.1m | 306,912 | 7% | added | |
| 46 | BCAX BICARA THERAPEUTICS INC | 0.6% | $4.0m | 250,606 | – | new | |
| 47 | BENITEC BIOPHARMA INC | 0.6% | $3.9m | 276,267 | 9% | added | |
| 48 | KINIKSA PHARMACEUTICALS INTL | 0.5% | $3.5m | 88,910 | 17% | added | |
| 49 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.5% | $3.4m | 141,238 | 2725% | added | |
| 50 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.5% | $3.3m | 230,837 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.